Legislative Activity

This resolution expresses strong support for honoring Earth Day and recognizes its historical importance in launching the modern environmental movement. It highlights ongoing challenges like climate change while celebrating recent landmark investments in clean energy and infrastructure. Ultimately, the bill urges the President to issue a proclamation recognizing Earth Day and encourages all Americans to take sustained action to protect the environment for future generations.

The Diesel Emissions Reduction Act of 2025 reauthorizes the existing federal program dedicated to reducing harmful diesel emissions. This legislation extends the authorization for funding and implementing emission reduction projects through the year 2029. By doing so, it ensures the continuation of efforts to clean up diesel pollution for an additional five years.

The Broadcast Freedom and Independence Act of 2025 aims to safeguard the independence of the Federal Communications Commission (FCC) from political pressure. It explicitly prohibits the FCC from revoking broadcast licenses or denying business transactions based on the viewpoints or opinions expressed by broadcasters. This legislation ensures that regulatory actions are focused on legal compliance rather than content censorship.

The "Public Health Funding Restoration Act" aims to fully fund the Prevention and Public Health Fund at $2,000,000,000 annually beginning in 2026. This will restore investments in crucial public health programs focused on preventing diseases, injuries, and chronic conditions. By ensuring consistent funding, the act seeks to improve healthcare, quality of life, and preparedness for future health crises.

The "Finn Sawyer Access to Cancer Testing Act" expands healthcare coverage under Medicare, Medicaid, and CHIP to include comprehensive cancer diagnostic and laboratory tests, such as genomic sequencing, starting in 2027. It ensures coverage upon diagnosis, recurrence, and as needed for treatment planning. Additionally, the Act directs the Department of Health and Human Services to establish an education program to raise awareness among healthcare providers and the public about genomic testing and its applications in cancer care.

The Scientific EXPERT Act of 2025 aims to improve drug development for rare diseases by mandating science-focused meetings. These meetings, organized by the Reagan-Udall Foundation, will bring together experts to discuss challenges and opportunities in developing treatments for specific rare diseases. The FDA will participate in these meetings, and meeting outcomes will be published to inform future drug development efforts. The Act allocates funding for these meetings and requires reports to Congress on their impact.